Nothing Special   »   [go: up one dir, main page]

SG10201808743VA - Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa - Google Patents

Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa

Info

Publication number
SG10201808743VA
SG10201808743VA SG10201808743VA SG10201808743VA SG10201808743VA SG 10201808743V A SG10201808743V A SG 10201808743VA SG 10201808743V A SG10201808743V A SG 10201808743VA SG 10201808743V A SG10201808743V A SG 10201808743VA SG 10201808743V A SG10201808743V A SG 10201808743VA
Authority
SG
Singapore
Prior art keywords
mucosa
skin
compositions
active substance
administration
Prior art date
Application number
SG10201808743VA
Inventor
Jens Hansen
Lars Hellerung Christiansen
Original Assignee
Dermtreat Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermtreat Aps filed Critical Dermtreat Aps
Publication of SG10201808743VA publication Critical patent/SG10201808743VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D1/00—Treatment of filament-forming or like material
    • D01D1/02—Preparation of spinning solutions
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/52—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polymers of unsaturated carboxylic acids or unsaturated esters
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/56—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/88—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2201/00—Cellulose-based fibres, e.g. vegetable fibres
    • D10B2201/20—Cellulose-derived artificial fibres
    • D10B2201/28—Cellulose esters or ethers, e.g. cellulose acetate
    • D10B2201/30—Ethers, e.g. CMC
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2321/00—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D10B2321/08—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of unsaturated carboxylic acids or unsaturated organic esters, e.g. polyacrylic esters, polyvinyl acetate
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2321/00—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D10B2321/12—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
    • D10B2331/06—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyethers
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00—Medical; Hygiene

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Textile Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compositions comprising electrohydrodynamically obtained fibres for admin- istration of specific dosages of an active substance to skin or mucosa 5 The present invention relates to electrospun fibers comprising i) a hydrophilic polymer that is soluble in a first solvent, ii) a bioadhesive substance that is slightly soluble in said first solvent, iii) optionally, a drug substance. 10 Figure 1
SG10201808743VA 2014-06-10 2015-06-09 Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa SG10201808743VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201470342 2014-06-10
DKPA201470815 2014-12-22

Publications (1)

Publication Number Publication Date
SG10201808743VA true SG10201808743VA (en) 2018-11-29

Family

ID=53373453

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201808743VA SG10201808743VA (en) 2014-06-10 2015-06-09 Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
SG11201609881WA SG11201609881WA (en) 2014-06-10 2015-06-09 Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201609881WA SG11201609881WA (en) 2014-06-10 2015-06-09 Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa

Country Status (17)

Country Link
US (5) US10052291B2 (en)
EP (2) EP3154513B1 (en)
JP (2) JP6591536B2 (en)
KR (2) KR102185355B1 (en)
CN (1) CN107072937A (en)
AU (2) AU2015273608C1 (en)
BR (1) BR112016028961B1 (en)
CA (1) CA2950821C (en)
DK (1) DK3154513T3 (en)
ES (1) ES2763524T3 (en)
IL (3) IL291842A (en)
MX (2) MX2016015688A (en)
MY (1) MY173739A (en)
NZ (2) NZ727975A (en)
RU (2) RU2019121301A (en)
SG (2) SG10201808743VA (en)
WO (1) WO2015189212A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ201124A3 (en) 2011-01-17 2012-06-13 Elmarco S.R.O. Carrier for oromucosal, especially sublingual application of physiologically active compounds
WO2014071182A1 (en) 2012-11-01 2014-05-08 Massachusetts Institute Of Technology Directed evolution of synthetic gene cluster
WO2016079246A1 (en) * 2014-11-20 2016-05-26 Dermtreat Aps Bioadhesive films
MX2018000615A (en) 2015-07-13 2018-08-01 Pivot Bio Inc Methods and compositions for improving plant traits.
JP2018537119A (en) 2015-10-05 2018-12-20 マサチューセッツ インスティテュート オブ テクノロジー Nitrogen fixation using refactored nif clusters
EP3334412B1 (en) 2015-11-19 2021-10-20 Afyx Therapeutics A/S A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
KR20240129105A (en) 2017-01-12 2024-08-27 피벗 바이오, 인크. Methods and compositions for improving plant traits
ES2874787T3 (en) * 2017-01-23 2021-11-05 Afyx Therapeutics As Method for the preparation of electrospun fibers with a high content of a bioadhesive substance
CN110248647A (en) * 2017-01-23 2019-09-17 阿费克斯疗法有限公司 The method for manufacturing the double-layer product based on electrospinning fibre
CN106667913A (en) * 2017-02-13 2017-05-17 东华大学 Preparation method of drug-loading pH (Potential of Hydrogen) sensitive self-assembling liposome
CN107419432A (en) * 2017-08-03 2017-12-01 东华大学 A kind of sensitive medicament-carrying nano-fiber membrane and its preparation method and application
CN107447366A (en) * 2017-08-03 2017-12-08 东华大学 A kind of sensitive medicament-carried sustained release nano fiber films of pH and its preparation method and application
WO2019071246A2 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. Implantable depots for controlled release of analgesics to treat postoperative pain, and associated devices, systems, and methods
EP3701040A4 (en) 2017-10-25 2021-08-25 Pivot Bio, Inc. Methods and compositions for improving engineered microbes that fix nitrogen
WO2019081625A1 (en) 2017-10-25 2019-05-02 Allero Therapeutics Bvba Treatment of immune diseases by administration of antigen-specific formulations
EP3479693A1 (en) * 2017-11-01 2019-05-08 Everris International B.V. Sulfide containing polyester coatings for agrochemical composition
CN112367980A (en) 2018-05-12 2021-02-12 铸造疗法股份有限公司 Implantable reservoir for controlled release of therapeutic agents
CN108998847A (en) * 2018-08-25 2018-12-14 诺斯贝尔化妆品股份有限公司 A kind of preparation method of active nano inclusion enclave electrospun fibers film cloth
EP3843710A1 (en) 2018-08-28 2021-07-07 Foundry Therapeutics, Inc. Polymer implants
WO2020046973A1 (en) 2018-08-28 2020-03-05 Foundry Therapeutics 1, Inc. Devices, systems, and methods for delivering, positioning, and securing polymer depots in situ
AU2019394973A1 (en) * 2018-12-07 2021-06-03 Pivot Bio, Inc. Polymer compositions with improved stability for nitrogen fixing microbial products
CN114286668A (en) 2019-04-11 2022-04-05 铸造疗法股份有限公司 Local, sustained, controlled release implantable depot of therapeutic agents for treating cancer and related symptoms and conditions
FI20195397A1 (en) * 2019-05-14 2020-11-15 Capsamedix Oy Controlled release device for oral cavity
CN112107559B (en) * 2019-06-20 2023-09-08 普济生物科技（台州）有限公司 Oral transmucosal pharmaceutical dosage form
WO2021050532A1 (en) * 2019-09-09 2021-03-18 Afyx Therapeutics A/S Compositions for treating fungal infections
US20240074970A1 (en) 2019-10-08 2024-03-07 Afyx Therapeutics A/S Compositions for the delivery of proteins
US20230136789A1 (en) 2020-03-05 2023-05-04 Foundry Therapeutics, Inc. Polymer implants
ES2876401B2 (en) * 2020-05-11 2024-04-05 Bioinicia S L Self-adhesive fiber patches for the controlled release of bioactives
US20220175812A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
JP2024516108A (en) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート Rapid Design, Build, Test, and Learn Techniques for Identifying and Using Nonviral Carriers
PL4124336T3 (en) * 2021-07-30 2024-02-26 Cannamedical Pharma Gmbh Transmucosal patch comprising a cannabinoid and/or an opioid
CN118574602A (en) 2021-11-23 2024-08-30 阿费克斯发展有限公司 Mucosal patch and method of use thereof
CZ202242A3 (en) * 2022-01-28 2023-06-21 Ing Medical S.R.O. Covering agent containing an active substance
WO2024166100A1 (en) * 2023-02-08 2024-08-15 Epitomee Medical Ltd. Methods for preparing an active layer and devices comprising same
CN118557798A (en) * 2024-06-20 2024-08-30 苏州先觉新材料科技有限公司 Hydrogel-electrostatic spinning film double-layer mixed bracket and preparation method and application thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280423A (en) 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk Mucosal application agent in oral cavity
DE4337152A1 (en) * 1993-10-30 1995-05-04 Merck Patent Gmbh Process for the preparation of aqueous chitosan solutions and gels
EP1251829A4 (en) * 2000-01-28 2009-05-06 Smithkline Beecham Corp Electrospun pharmaceutical compositions
JP2004531301A (en) * 2001-03-22 2004-10-14 バテル メモリアル インスティチュート Manufacture of soluble formulations
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7309498B2 (en) * 2001-10-10 2007-12-18 Belenkaya Bronislava G Biodegradable absorbents and methods of preparation
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
KR100564366B1 (en) 2003-11-19 2006-04-07 재단법인서울대학교산학협력재단 Nonwoven nanofibrous membranes for guided tissue regeneration and their fabrication method
JP4526851B2 (en) * 2004-03-31 2010-08-18 明彦 谷岡 Polysaccharide nanoscale fibers and compacts
CN101039798B (en) * 2004-10-06 2012-03-07 纽约州立大学研究基金会 High flux and low fouling filtration media
US7390760B1 (en) * 2004-11-02 2008-06-24 Kimberly-Clark Worldwide, Inc. Composite nanofiber materials and methods for making same
WO2006106514A2 (en) * 2005-04-06 2006-10-12 Nicast Ltd. Electrospun dosage form and method of producing the same
US20100190254A1 (en) * 2006-12-05 2010-07-29 Nanyang Technological University Three-dimensional porous hybrid scaffold and manufacture thereof
US20100254961A1 (en) 2007-09-05 2010-10-07 Taiyokagaku Co., Ltd. Water-soluble electrospun sheet
US8361492B2 (en) 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
WO2010099292A2 (en) 2009-02-25 2010-09-02 North Carolina State University Biodegradable drug or other active delivery system
US20110111012A1 (en) * 2009-11-12 2011-05-12 Hemcon Medical Technologies, Inc. Nanomaterial wound dressing assembly
RU2487701C2 (en) * 2011-07-26 2013-07-20 Общество с ограниченной ответственностью "Инмед" Solution for preparing chitosan material, method for preparing haemostatic material of this solution (versions) and medical device with using chitosan fibres
US9393216B2 (en) * 2012-11-06 2016-07-19 University Of Washington Through Its Center For Commercialization Vaginal matrices: nanofibers for contraception and prevention of HIV infection
EP2813212A1 (en) * 2013-06-10 2014-12-17 Zentiva, a.s. Drug formulation using API in nanofibers
ES2874787T3 (en) * 2017-01-23 2021-11-05 Afyx Therapeutics As Method for the preparation of electrospun fibers with a high content of a bioadhesive substance

Also Published As

Publication number Publication date
MX2016015688A (en) 2017-05-30
US20170119690A1 (en) 2017-05-04
EP3154513B1 (en) 2019-11-20
CN107072937A (en) 2017-08-18
MY173739A (en) 2020-02-18
RU2695217C2 (en) 2019-07-22
IL291842A (en) 2022-06-01
ES2763524T3 (en) 2020-05-29
US10052291B2 (en) 2018-08-21
KR102185355B1 (en) 2020-12-02
DK3154513T3 (en) 2020-01-27
US20240058276A1 (en) 2024-02-22
IL264413B (en) 2022-04-01
MX2021001118A (en) 2021-07-02
WO2015189212A1 (en) 2015-12-17
AU2019204518B2 (en) 2020-07-16
IL249036A0 (en) 2017-01-31
BR112016028961A2 (en) 2017-08-22
RU2016151163A3 (en) 2018-12-26
RU2019121301A (en) 2019-08-20
US20180325834A1 (en) 2018-11-15
RU2016151163A (en) 2018-07-10
SG11201609881WA (en) 2016-12-29
EP3622947A1 (en) 2020-03-18
NZ727975A (en) 2019-01-25
US20230210784A1 (en) 2023-07-06
KR102127344B1 (en) 2020-06-29
NZ746573A (en) 2023-07-28
KR20200078682A (en) 2020-07-01
AU2015273608A1 (en) 2017-01-19
JP2017517577A (en) 2017-06-29
IL264413A (en) 2019-02-28
JP6770157B2 (en) 2020-10-14
KR20170016970A (en) 2017-02-14
AU2015273608B2 (en) 2019-04-04
JP2019218400A (en) 2019-12-26
JP6591536B2 (en) 2019-10-16
BR112016028961B1 (en) 2023-04-11
US20220105049A1 (en) 2022-04-07
CA2950821A1 (en) 2015-12-17
BR112016028961A8 (en) 2021-06-29
IL249036B (en) 2019-02-28
CA2950821C (en) 2024-02-06
AU2015273608C1 (en) 2019-08-15
AU2019204518A1 (en) 2019-07-18
EP3154513A1 (en) 2017-04-19

Similar Documents

Publication Publication Date Title
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
MY167777A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
SG11201808019WA (en) Edaravone formulations
PE20150668A1 (en) NON-AQUEOUS TOPICAL PHARMACEUTICAL FORMULATIONS
MX2021006035A (en) Stable cannabinoid formulations.
CO2018013747A2 (en) Modulators of the spiro-lactam n-methyl-d-aspartate receptor and uses thereof
WO2017037594A3 (en) Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition
IN2013MU03583A (en)
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
MX2017004772A (en) Compositions and methods for physiological delivery using cannabidiol.
CY1124041T1 (en) COMPOSITIONS CONTAINING CYCLOSPORIN
EA201992832A1 (en) SCREAM INTRODUCTION ADAMTS13
PH12015502556A1 (en) Modified release formulation
MX2016015211A (en) Topical formulations and uses thereof.
MD3482754T2 (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
MX2016015261A (en) Allisartan isoproxil solid dispersion and pharmaceutical composition thereof.
WO2016040814A3 (en) Disulfide polymers and methods of use
CL2018003682A1 (en) Oral pharmaceutical composition, comprising a pharmaceutically active agent, at least one bioadhesive cationic polymer and at least two anionic polymers.
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
MX2015015537A (en) Nicotine lozenge formulation.
MX2018009739A (en) The combined administration of a penetration agent and a sulfur containing compound to plants.
TR201903234T4 (en) Pharmaceutical solution containing dopamine for use in the treatment of Parkinson's disease.
EA201691596A1 (en) HEPARINE COMPOSITIONS FOR EXTERNAL USE
AR106750A1 (en) HIV MATURATION INHIBITOR FORMULATIONS
IN2015DE03084A (en)